EU & Dutch Funding Programmes
Translating European and Dutch funding landscapes into realistic development pathways for life science innovation.
European and Dutch funding programmes offer significant opportunities for life science innovation. However, navigating these funding landscapes requires strategic positioning, proposal structuring, and alignment with evaluation criteria.
PROMAFUN CRIO supports research teams and companies in translating their scientific innovations into competitive funding proposals and realistic development pathways.
Most Teams Can Find Calls. Few Can Select Them Strategically.
European and Dutch non-dilutive funding programmes offer a wide range of instruments for life science, research, validation, and innovation.
Most teams can identify relevant calls.
Few teams can determine whether those instruments are realistically aligned with their scientific maturity, data readiness, development risks, and regulatory trajectory.
As a result, many applications fail not because of weak science, but because of misaligned funding decisions.
PROMAFUN CRIO focuses on preventing this misalignment.
Before you commit to a funding opportunity
Not every funding opportunity is a strategic fit for your organisation or project stage. Differences in scope, consortium requirements, co-funding obligations and implementation timelines can significantly affect feasibility and outcomes.
PROMAFUN CRIO supports organisations at an early stage in assessing relevance, timing and positioning before committing resources to proposal development or consortium engagement.
How We Translate Funding Landscapes Into Decisions
Programme mapping is not the creation of funding lists.
It is the structured integration of funding instruments into your development strategy.
We analyse funding opportunities in relation to:
• Technology and adoption readiness levels (TRL/ARL)
• Validation and development milestones
• Regulatory and compliance pathways
• Consortium requirements and governance structures
• Resource availibility and operational capacity
• Evaluation criteria and scoring logic
This enables evidence-based funding decisions rather than opportunistic submissions.
Typical Funding Pathways in Life Science Development
Succesful teams rarely move through funding programmes in isolation.
They progress through structured funding sequences aligned with development maturity.
Examples include:
• Early validation → EIC Pathfinder → EIC Transition
• Applied R&D → Eurostars → Horizon collaborative projects
• National feasibility → ZonMw → EU health programmes
These pathways are shaped by data readiness, risk profile, and strategic positioning.
How Programme Mapping Reduces Strategic Risk
Our programme mapping integrates funding decisions with development reality.
We ensure that:
• Instrument selection reflects scientific readiness
• Submission timing matches data availability
• Consortium structures support evaluation criteria
• Funding pathways reinforce valuation milestones
• Non-dilutive and dilutive financing are aligned
This reduces rework, delays, and misallocated resources.
Integration With Funding Strategy and Proposal Development
Programme mapping is embedded within our broader funding framework.
It informs:
• Funding Assessment & Strategy
• Grant Writing & Proposal Positioning
• Dissemination & Impact Planning
• Grant Management & Coordination
This ensures that landscape analysis translates into executable funding trajectories.
What Teams Commonly Get Wrong
Without structured programme mapping, teams often:
• Apply prematurely or too late
• Target formally eligible but strategically unsuitable calls
• Underestimate consortium complexity
• Misinterpret evaluation priorities
• Accumulate fragmented development data
• Delay critical validation studies
These errors increase development cost and reduce long-term funding credibility.
When Programme Mapping Is Most Relevant
Our programme mapping support is particularly valuable when:
• Entering EU or national non-dilutive funding for the first time
• Preparing multi-stage development programmes
• Building international research consortia
• Evaluating alternative financing routes
• Planning scale-up trajectories
What Clients Gain
Through structured programme mapping, teams gain:
• Clarity on realistic funding options
• Reduced application waste
• Improved evaluation alignment
• Coherent development sequencing
• Increased funding predictability
• Stronger investor positioning
This supports sustainable innovation rather than short-term grant chasing.
Discuss Your Funding Trajectory?
Speak with an Expert
If you are navigating European or Dutch funding programmes and require structured guidance on viable funding pathways, we invite you to discuss your project context with our team.
